Divergent Roles of C AAX Motif-signaled Posttranslational Modifications in the Regulation and Subcellular Localization of Ral GTPases by Gentry, Leanna R. et al.
Divergent Roles of CAAX Motif-signaled Posttranslational
Modifications in the Regulation and Subcellular Localization
of Ral GTPases*
Received for publication, April 3, 2015, and in revised form, July 23, 2015 Published, JBC Papers in Press, July 27, 2015, DOI 10.1074/jbc.M115.656710
Leanna R. Gentry‡1, Akiyuki Nishimura§, Adrienne D. Cox‡¶, Timothy D. Martin‡, Denis Tsygankov‡,
Motohiro Nishida§, Timothy C. Elston‡, and Channing J. Der‡2
From the Departments of ‡Pharmacology and ¶Radiation Oncology, and Lineberger Comprehensive Cancer Center, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 and the §Division of Cardiocirculatory Signaling, Okazaki Institute
for Integrative Bioscience (National Institute for Physiological Sciences), National Institutes of Natural Sciences, 5-1 Higashiyama,
Myoudaiji-cho, Okazaki, Aichi 444-8787, Japan
Background: The highly related small GTPases RalA and RalB exhibit distinct functions in cancer cell processes.
Results: Posttranslational modifications signaled by the C-terminal CAAX motif contribute to Ral isoform differences in
subcellular localization, activation, and protein stability.
Conclusion: Modifications catalyzed by RCE1, ICMT, and protein palmitoyl acyltransferase cause Ral isoform-specific func-
tional consequences.
Significance: Inhibitors of CAAX motif modifications will have complex consequences on Ral GTPase regulation.
The Ras-like small GTPases RalA and RalB are well vali-
dated effectors of RAS oncogene-driven human cancer
growth, and pharmacologic inhibitors of Ral function may
provide an effective anti-Ras therapeutic strategy. Intrigu-
ingly, although RalA and RalB share strong overall amino acid
sequence identity, exhibit essentially identical structural and
biochemical properties, and can utilize the same downstream
effectors, they also exhibit divergent and sometimes oppos-
ing roles in the tumorigenic and metastatic growth of differ-
ent cancer types. These distinct biological functions have
been attributed largely to sequence divergence in their car-
boxyl-terminal hypervariable regions. However, the role of
posttranslational modifications signaled by the hypervariable
region carboxyl-terminal tetrapeptide CAAX motif (C  cys-
teine, A  aliphatic amino acid, X  terminal residue) in Ral
isoform-selective functions has not been addressed. We
determined that these modifications have distinct roles and
consequences. Both RalA and RalB require Ras converting
CAAX endopeptidase 1 (RCE1) for association with the
plasma membrane, albeit not with endomembranes, and loss
of RCE1 caused mislocalization as well as sustained activa-
tion of both RalA and RalB. In contrast, isoprenylcysteine
carboxylmethyltransferase (ICMT) deficiency disrupted
plasma membrane localization only of RalB, whereas RalA
depended on ICMT for efficient endosomal localization. Fur-
thermore, the absence of ICMT increased stability of RalB but
not RalA protein. Finally, palmitoylation was critical for subcel-
lular localization of RalB but not RalA. In summary, we have
identified striking isoform-specific consequences of distinct
CAAX-signaled posttranslational modifications that contribute
to the divergent subcellular localization and activity of RalA and
RalB.
The Ras-like (Ral) small GTPases (RalA and RalB) are mem-
bers of the Ras branch of the Ras superfamily of small GTPases
(1–3). Like Ras, Ral small GTPases function as molecular on-off
switches and cycle between inactive GDP- and active GTP-
bound states. The cycle is catalyzed by Ral-selective guanine
nucleotide exchange factors (RalGEFs)3 and GTPase-activating
proteins (RalGAPs), which accelerate slow intrinsic exchange
and GTPase activities, respectively (4). Ral GTPases are acti-
vated downstream of Ras oncoproteins. Activated Ras-GTP
binds to and activates RalGEFs (e.g. RalGDS), stimulating for-
mation of Ral-GTP. Active Ral-GTP binds preferentially to a
spectrum of functionally diverse downstream effectors to reg-
ulate a diversity of cellular processes that include actin cyto-
skeletal organization, endocytosis and exocytosis, and mito-
chondrial function (5– 8), as well as cell proliferation, survival,
and autophagy (9, 10). The best validated effectors of Ral are the
Sec5 and Exo84 subunits of the exocyst complex and RalBP1/
RLIP76, a GAP for Rho family small GTPases (1–3).
RalA and RalB share significant overall sequence, structural,
and biochemical identity (3). Their amino-terminal G-domains
(amino acids 12–176) involved in GTP binding and hydrolysis,
RalGEF and RalGAP regulation, and effector binding share 88%
sequence identity. Remarkably, despite their regulation by
shared GEFs and GAPs and interaction with shared effectors in
vitro, RalA and RalB display divergent biological roles in normal
and neoplastic cell growth. RalB was found to be specifically
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required for survival of tumor but not normal cells (11). In
contrast, RalA was dispensable for survival, but was required for
anchorage-independent proliferation. Differences in Ral iso-
form function have also been observed in various cancer types.
Distinct aspects of cell migration were differentially regulated
by RalA versus RalB in bladder cancer cells (12). RalA was essen-
tial for tumorigenic growth of pancreatic cancer cells, whereas
RalB was required for invasive and metastatic growth (13). In
contrast, RalA promoted whereas RalB antagonized anchorage-
independent growth of colorectal carcinoma cells (14).
Like Ras, Ral proteins terminate in carboxyl-terminal CAAX
tetrapeptide motifs (where C  cysteine, A  aliphatic amino
acid, and X  terminal amino acid; Ral amino acids 203–206),
which signal for a series of posttranslational modifications that
facilitate intracellular trafficking and translocation to the
plasma membrane. CAAX-signaled modifications begin with
covalent addition of an isoprenoid lipid to the cysteine residue
of the CAAX motif (15). The X residue determines protein pre-
nyltransferase specificity (16). RalA and RalB proteins, both of
which terminate in leucine, are modified by addition of a gera-
nylgeranyl lipid, catalyzed by cytosolic geranylgeranyltrans-
ferase-I (GGTase I) (17, 18). Subsequent cleavage of the -AAX
tripeptide by endoplasmic reticulum-associated Ras converting
CAAX endopeptidase 1 (RCE1) leaves a lipid-modified terminal
cysteine. This cysteine is then methylated by endoplasmic retic-
ulum-associated isoprenylcysteine carboxylmethyltransferase
(ICMT) (19).
The RalA and RalB functional differences identified to date
have been attributed to the carboxyl-terminal sequences imme-
diately adjacent to their CAAX motifs (7, 20). Termed the
hypervariable region (HVR; amino acids 177–202), this
sequence exhibits the greatest divergence between RalA and
RalB (44% identity) and confers secondary membrane-target-
ing specificity. In particular, the RalA and RalB carboxyl termini
possess phosphorylation sites recognized by distinct protein
kinases, where phosphorylation causes translocation from the
plasma membrane to endomembranes and a change in effector
interaction (21–25). However, posttranslational modifications
at other sites may also play an important role in Ral isoform
functions.
A recent study of the brain-specific isoform of the Rho family
small GTPase Cdc42 concluded that proteins terminating in a
CA1A2X motif in which the A1 residue is a cysteine (CA1A2X 
CCAX) can undergo an alternative processing pathway (26).
Although a majority of Cdc42 undergoes the conventional
post-prenyl modification pathway involving RCE1 and ICMT, a
subset (5–20%) does not undergo RCE1-catalyzed removal of
the AAX residues, and instead the A1 cysteine is covalently
modified by palmitoylation. The resulting dually lipid-modi-
fied, nonmethylated pool of Cdc42 is no longer regulated by
RhoGDI, leading to enhanced plasma membrane association.
The CAAX motif of RalA is CCIL, and that of RalB is CCLL (27),
suggesting that, like Cdc42, Ral proteins may also undergo this
alternative processing. However, unlike Cdc42, the membrane
association of RalA and RalB is not regulated by RhoGDI.
Although both RalA and RalB were verified to undergo palmi-
toylation of the A1 cysteine of their CA1A2X motifs (26), the
impact of dual lipid modification of the CAAX motif on Ral
subcellular localization was not determined.
Additionally, the contributions of the CAAX-signaled RCE1
and ICMT modifications to RalA and RalB subcellular localiza-
tion and membrane association have not been addressed. We
therefore determined the consequences of RCE1 or ICMT defi-
ciency on these properties of each Ral isoform. We found that
both RalA and RalB required RCE1 for efficient plasma mem-
brane targeting, whereas only RalB required ICMT for this
association. Interestingly, whereas RalA could still concentrate
at the plasma membrane in the absence of ICMT, it depended
on ICMT for localization to recycling endosomes. We also
found that RCE1 deficiency increased steady-state activity of
both RalA and RalB, whereas ICMT deficiency increased
steady-state levels of RalB but not RalA. Finally, we determined
that CA1AX palmitoylation was essential for plasma membrane
association of RalB, but not of RalA. Pharmacologic inhibitors
of RCE1 and ICMT are being considered as anti-Ras therapeu-
tic strategies (28). Because Ral GTPases are key drivers of Ras-
dependent cancer growth, it will be critical to understand the
complex and differential consequences of RCE1 and ICMT
inhibition for Ral function.
Experimental Procedures
Plasmids and Cell Lines—cDNAs encoding green fluorescent
protein (GFP)-tagged human RalA was described previously
(22) and RalB was generated for this study as described for RalA.
Site-directed mutagenesis was done to generate cysteine to ser-
ine missense mutants of the A1 cysteine residue of the Ral
CCI/LL CA1A2X motif, which were then subcloned into
pEGFP-C3. The pEGFP-RalA/B chimeric construct was pro-
vided by Dr. Christopher Counter (Duke University). The
RalB/A chimeric cDNA was subcloned into pEGFP between the
BamHI and XbaI sites. The pCDH-mCh lentivirus expression
vector encoding mCherry-tagged RalA was previously de-
scribed (21). All constructs were sequence-verified, and cloning
details are available upon request. Mouse embryo fibroblasts
(MEFs) deficient in RCE1 (Rce1/) or ICMT (Icmt/) were
provided by Dr. Steven Young (UCLA) and cultured as
described previously (29, 30).
Transfection, Transferrin Labeling, and Microscopy—Cells
were plated, transfected, and imaged as described previously
(31). Lipofectamine Plus was used for DNA transfections.
Three h after transfection, cells were washed and cultured in
phenol red-free Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum. Cells were labeled with
transferrin following the manufacturer’s protocol (Life Tech-
nologies). Cells were imaged in 35-mm culture dishes contain-
ing a 15-mm coverslip on the bottom made of number 1.5 glass
(MatTek). Cells were examined with an inverted laser-scanning
confocal microscope (Zeiss 710 LSM) using an oil immersion
63 objective with a 1.4 numerical aperture. Images of GFP
expression were captured by scanning with a 488-nm line of a
solid-state laser using a BP 490 –555 emission filter. Images of
mCh and red fluorescent transferrin probes were captured by
scanning with a 555-nm solid-state laser with the variable sec-
ondary dichroic set to 580 nm. Images were processed with
ImageJ software, and thresholded Manders coefficients were
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calculated using the colocalization threshold plugin from the
Wright Cell Imaging Facility.
GST Pulldown Assays—Endogenous activated RalA- and
RalB-GTP were assayed as we described previously, by pull-
down analyses using GST-Sec5-RBD (glutathione S-transferase
fusion of the Ral-GTP binding domain of Sec5) (20). After SDS-
PAGE and immunoblotting with the RalA- (BD Biosciences) or
RalB (Millipore)-specific antibodies, the amount of active Ral-
GTP was normalized to total Ral protein levels in total cellular
lysates. Western blot analyses with anti--actin (Sigma) or anti-
GAPDH (Sigma) were done to verify equivalent loading of total
cellular protein.
Detection of Protein Palmitoylation—Palmitoylated proteins
were purified using acyl-resin-assisted capture (acyl-RAC).
Cells were lysed with RIPA buffer (20 mM Hepes-NaOH, pH
7.4, 100 mM NaCl, 3 mM MgCl2, 1% Triton X-100, 0.5% deoxy-
cholate, and 0.1% SDS) supplemented with protease inhibitor.
Cleared lysates were incubated in RIPA buffer containing 0.1%
methyl methanethiosulfonate at 42 °C for 30 min with rotation.
Proteins were precipitated with acetone, and then resuspended
in binding buffer (100 mM Hepes-NaCl, pH 7.4, 1 mM EDTA,
and 1% SDS). Samples were mixed with thiopropyl-Sepharose
in the presence of 250 mM hydroxylamine to cleave thioester
linkages. As a negative control, the same volume of NaCl was
added instead of hydroxylamine. After a 3-h rotation at room
temperature, the resins were washed four times with binding
buffer, and samples were eluted in buffer containing 50 mM
Tris-HCl, pH 6.8, 50 mM DTT, 10% glycerol, and 1% SDS. After
immunoblotting with the RalA- and RalB-specific antibodies,
the palmitoylation stoichiometry was calculated by a ratio of
the precipitate intensity to the input intensity.
Quantification of Fluorescence—The statistics of fluores-
cence intensity were extracted from images of individual cells as
a function of the distance from the cell edge. Cell masks (binary
images) were obtained by thresholding with the MovThresh
module of the CellGeo package (32). Each cell mask was then
morphologically eroded using the MATLAB function “imer-
ode” with a disk radius 1 to 50 pixels as a structural element. At
each step of the morphological erosion, the boundary was
traced and the intensity of the corresponding boundary pixels
was determined from the original image. This allowed the
mean, median, and standard deviation to be calculated for each
cell as function of the distance 1 to 50 pixels from the cell edge.
Finally, the intensity profiles for individual cells were normal-
ized to their peak (max) values, and then averaged over all cells
in a given genotype. These four processing steps constitute a
single MATLAB code for batch processing.
Results
RalA and RalB Show Distinct Requirements for RCE1- and
ICMT-mediated Posttranslational Modifications for Their Sub-
cellular Localization and Plasma Membrane Association—We
first addressed the importance of RCE1- and ICMT-catalyzed
modifications in regulating RalA and RalB subcellular localiza-
FIGURE 1. Subcellular localization of Ral family proteins is differentially dependent on RCE1 and ICMT processing. Wild-type (WT), Rce1/, and Icmt/
MEFs were transiently transfected with expression vectors encoding EGFP-tagged RalA or RalB. A, live cells were visualized using confocal microscopy. Images
shown are representative of three independent experiments, each of which examined 40 cells. Images were analyzed using our MATLAB image processing
script, for B, EGFP-RalA distribution, and C, EGFP-RalB distribution in WT, Rce1/, and Icmt/ MEFs. Scale bar, 10 m.
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tion and membrane association. Because there are currently
no potent and selective pharmacologic inhibitors of these
enzymes, we utilized MEFs deficient in expression of either
RCE1 or ICMT (29, 30). We transiently transfected wild-type
(WT), Rce1/, or Icmt/ MEFs with expression constructs
encoding RalA or RalB, which were amino terminally tagged
with GFP (Fig. 1A). To quantitate changes in Ral plasma mem-
brane association, we developed a MATLAB image processing
script to analyze fluorescence measurements for localization
patterns in individual cells (Fig. 1, B and C). In particular, we
quantified the GFP intensity as a function of the distance from
the plasma membrane to the nucleus. As described previously
(6, 7, 21), we found that RalA and RalB each exhibited both
plasma membrane and endosome localization in WT MEFs
(Fig. 1A). However, we found that in Rce1/ MEFs, both RalA
and RalB were mislocalized, with diminished plasma mem-
brane association and increased diffuse cytoplasmic accumula-
tion, although their endosome localization remained intact
(Fig. 1A). These results were somewhat unexpected, because a
previous study suggested that small GTPases modified by the
hydrophobic geranylgeranyl lipid attached to Ral proteins
would not be highly dependent on ICMT- and RCE1-catalyzed
modifications for efficient plasma membrane association (33).
Because RCE1 deficiency also prevents the subsequent
ICMT modification, we next determined the consequences of
ICMT deficiency alone. Although the plasma membrane tar-
geting of both Ral isoforms depended similarly on RCE1, sur-
prisingly, we found a differential requirement for ICMT in reg-
ulating RalA versus RalB plasma membrane targeting. In
Icmt/ MEFs, we observed that RalA remained concentrated
at the plasma membrane, similar to its localization in WT
MEFs. Thus, the significant disruption of RalA plasma mem-
brane association in Rce1/ cells was caused by the absence of
AAX proteolysis. In striking contrast, RalB association with the
plasma membrane was reduced significantly in Icmt/ MEFs,
instead showing increased diffuse localization in the cytosol.
Thus, plasma membrane association of RalB displays a greater
requirement for ICMT compared with that of RalA.
We next investigated the basis for the different susceptibility
of RalA and RalB to ICMT deficiency. Although their sequence
divergence is greatest in the HVR (44% identity), there is also
significant sequence divergence in the carboxyl-terminal por-
tion of the G-domain (residues 91–153; 68% identity) (Fig. 2A).
To distinguish between the importance of these two blocks of
sequence divergence in ICMT-dependent Ral localization, we
utilized chimeric RalA and RalB proteins that terminate in the
reciprocal HVR (Fig. 2A). RalA/B is comprised of the RalA N
terminus (residues 1–176), which includes RalA sequences
involved in effector and regulatory protein binding, and the
carboxyl-terminal HVR of RalB (residues 177–204) involved in
membrane targeting. Conversely, RalB/A is comprised of the N
terminus of RalB (residues 1–176) followed by the carboxyl-
terminal HVR of RalA (residues 177–204). We transiently
expressed GFP fusion proteins of RalA, RalB, RalA/B, or RalB/A
in WT or Icmt/ MEFs and observed their localization pat-
terns. As expected, in WT MEFs the RalA/B and RalB/A chi-
meric proteins retained the predominantly plasma membrane
localization patterns of full-length RalA and RalB (data not
shown). However, in Icmt/ MEFs, whereas RalB/A retained
the strong plasma membrane subcellular localization of full-
length RalA (Fig. 2, A and B), the RalA/B chimeric protein
exhibited a loss of plasma membrane association similar to that
seen with full-length RalB. We conclude that the distinct con-
sequences of ICMT deficiency seen with RalA and RalB are
due to sequence divergence in the HVR rather than in the
G-domain.
Icmt Regulates RalA Localization to Recycling Endosomes—
Although ICMT deficiency did not noticeably impact RalA
plasma membrane targeting, we did observe a decreased level of
endomembrane-associated RalA in Icmt/ MEFs (Fig. 1A).
Therefore, we used our MATLAB image processing script to
quantify the spatial distribution of GFP-RalA. Our analysis
revealed a decreased concentration of RalA closer to the
nucleus in Icmt/ MEFs. In contrast, RalB association with
internal organelles was not impacted significantly by ICMT
deficiency (Fig. 1B). Thus, RalA and RalB association with
endomembranes exhibited different requirements for ICMT.
FIGURE 2. Hypervariable domain dictates Ral ICMT dependence. A, chime-
ric Ral proteins were constructed by a reciprocal switch of the carboxyl-ter-
minal residues 176 –206 (red arrow) comprised of the hypervariable domain
and the CAAX motif. RalA/B is comprised of the RalA G-domain (residues
1–176) followed by RalB residues 177–206, whereas RalB/A is comprised of
the RalB G-domain (residues 1–176) followed by RalA residues 177–206. WT,
Rce1/, and Icmt/ MEF cells were transiently transfected with expression
constructs encoding EGFP-tagged Ral chimeras RalA/B or RalB/A. B, live cells
were visualized by confocal microscopy. Images shown are representative of
three independent experiments, each of which examined 40 cells. C,
images from B were analyzed using our MATLAB image processing script.
Scale bar, 10 m.
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Because RalA is known to localize to recycling endosomes in
various cell types (6, 7), we speculated that the RalA endomem-
brane localization that was disrupted in the absence of ICMT
included this compartment. To address this possibility, we
detected recycling endosomes by live cell microscopy using a
fluorescent transferrin probe, and measured the colocalization
of GFP-RalA with transferrin-loaded endosomes. Image analy-
sis revealed a significant decrease in colocalization of RalA with
transferrin in Icmt/ MEFs compared with WT MEFs, indi-
cating that RalA localization to recycling endosomes was
impaired in the absence of ICMT (Fig. 3, A and B).
To further validate this finding, we also measured RalA colo-
calization with a second marker of recycling endosomes, Rab9.
For these analyses, we co-transfected expression vectors encod-
ing mCherry-tagged RalA and GFP-Rab9 into WT or Icmt/
MEFs. Colocalization analysis again showed a significant
reduction in localization of RalA to Rab9-containing endo-
somes in Icmt/ MEFs (Fig. 3, C and D). These results dem-
onstrate that loss of ICMT significantly impaired RalA localiza-
tion to recycling endosomes.
RCE1 Regulates Ral Activity—Because we previously ob-
served that phosphorylation-mediated translocation of RalA
or RalB from the plasma membrane to endosomes was asso-
ciated with an increase in active GTP-bound protein (21, 22),
we speculated that the altered subcellular localization of
RalA and RalB seen in RCE1- or ICMT-deficient cells might
also be accompanied by altered regulation of their GDP-GTP
cycle and consequently of their activation state. To address
this possibility, we first performed pulldown analyses to
determine the level of activated, GTP-bound endogenous
RalA and RalB in WT, Rce1/, and Icmt/ MEFs. When
normalized to total protein, we found that the steady-state
levels of both endogenous RalA-GTP and RalB-GTP were
elevated strikingly in Rce1/ MEFs compared with WT
MEFs (Fig. 4A). In contrast, there was limited increase in
RalA-GTP and no increase in RalB-GTP levels in Icmt/
MEFs, although RalB protein levels were markedly higher in
these cells compared with WT MEFs.
The elevated activity of the Ral GTPases observed in the
absence of RCE1 when compared with WT cells suggests dif-
ferential regulation of the mislocalized Ral proteins by their
regulatory RalGAPs or RalGEFs. To address this possibility, we
evaluated the kinetics of RalA-GTP formation in response to
external stimuli. Growth factor-stimulated Ral activation is
mediated through transient activation of Ras, leading to Ral-
GEF activation and a rapid and transient increase in RalA-GTP
(34), with RalGAP activity then terminating the activation. A
previous study showed that, in cells depleted of RalGAP, EGF
treatment resulted in an increased level of Ral activation and a
decreased rate of termination of activation, leading to sustained
Ral activity in stimulated cells (35). Therefore, we compared the
kinetics of endogenous Ral-GTP formation in response to EGF
in WT versus Rce1/ MEFs.
We stimulated serum-starved WT and Rce1/ MEFs with
EGF and then monitored the GTP-bound levels of RalA and
RalB over time by pulldown analyses (Fig. 4B). Although the
FIGURE 3. RalA localization on recycling endosomes is impaired by loss of ICMT. A, WT and Icmt/ MEF cells were transiently transfected with an
expression construct encoding EGFP-RalA and incubated with pHrodo red transferrin conjugate for 30 min before visualization by confocal microscopy. The
images were overlapped (Merge) to indicate the degree of colocalization on endosomes in WT cells compared with Icmt/. B, 25 images per condition were
quantified. Values shown are means of Manders coefficients using thresholds  S.E., and an unpaired t test was used to determine significance (p  0.05). C, WT
and Icmt/ MEF cells were transiently transfected with expression constructs encoding EGFP-Rab9 and mCh-RalA. Cells were visualized by confocal micros-
copy. Images were merged as described for panel A, and in D were quantified as described in panel B. Scale bar, 10 m.
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activity of both RalA and RalB increased in response to EGF
stimulation and returned to near basal levels at the same rate in
both cell types, we did find that EGF stimulation caused a sig-
nificantly greater initial increase in RalA-GTP and RalB-GTP
activity in Rce1/ MEFs compared with WT MEFs (Fig. 4, C
and D). Thus, the Ral mislocalization that we observed in
Rce1/ MEFs is more likely to alter their regulation by one or
more of the 6 RalGEFs than by RalGAPs (3).
Icmt Regulates RalB Stability—As described above, we
observed that levels of endogenous RalB but not RalA proteins
were stably elevated in Icmt/ MEFs compared with WT
MEFs (Fig. 4A). Previous studies demonstrated that RhoA pro-
tein was destabilized upon pharmacologic inhibition or genetic
loss of ICMT, whereas Ras protein was stabilized (36, 37).
Although we did find that the steady-state transcript levels of
RalB were slightly greater in Icmt/ MEFs compared with WT
MEFs (Fig. 5A), this small change likely was an insufficient basis
for the large difference in abundance of RalB protein in the two
cell types (Fig. 5B). We therefore hypothesized that the
increases in RalB protein in Icmt/ MEFs were due to altered
regulation of RalB stability in the absence of ICMT.
To investigate if RalB turnover was affected by loss of ICMT,
we treated WT and Icmt/ MEFs with cycloheximide to block
protein synthesis and then measured changes in protein levels
as the pre-existing RalB protein was degraded over time. We
found that RalB exhibited a shorter half-life in WT MEFs com-
pared with Icmt/ MEFs, with only 20% RalB protein remain-
ing in WT MEFs after 18 h of cycloheximide treatment com-
pared with 60% in Icmt/ MEFs (Fig. 5C). This difference
indicates that ICMT regulates RalB protein stability and pro-
motes its degradation.
Dual Lipid Modification of the Ral CAAX Motif Affects RalB
Subcellular Localization—In addition to the conventional
modification pathway involving RCE1 and ICMT, RalA and
RalB can also undergo an alternative pathway, whereby the
newly GGTase I-modified protein does not undergo subse-
quent RCE1-mediated proteolytic removal of the A1A2X res-
idues but instead undergoes palmitoylation of the cysteine
residue at the A1 position (26). Although the mechanism that
regulates which pathway will be taken has not been eluci-
dated, it was reported that the level of palmitoylation of RalA
was increased in RCE1-deficient MEFs. Thus, impairment of
one pathway can then favor a shift to the other pathway. We
hypothesized that the altered subcellular localization of
RalA and RalB that we observed in Rce1/ MEFs (Fig. 1)
might reflect not only loss of the RCE1- and ICMT-catalyzed
modifications but additionally reflect alterations in dual lipi-
dation by geranylgeranylation and palmitoylation of the
CAAX motif.
To determine a role for this alternative dual lipid modifica-
tion pathway in regulating RalA and RalB localization, we first
generated the same palmitoylation-deficient Ral mutants uti-
FIGURE 4. RCE1 deficiency increases activated Ral-GTP formed upon EGF stimulation. A, endogenous levels of RalA-GTP and RalB-GTP were
compared in WT, Rce1/, and Icmt/ MEFs by a pulldown assay using GST-Sec5 RBD. Western blot analyses were done with anti-RalA or anti-Ral
antibody to determine levels of Ral-GTP and total Ral proteins. -Actin was used to verify equivalent total protein loading. B, WT and Rce1/ MEFs were
serum-starved then stimulated with EGF. Cells were lysed at the indicated time points, followed by Western blot analyses as described in panel A. C,
RalA-GTP, and D, RalB-GTP expression levels were quantified by densitometry of Western blot data in panel B and normalized to total RalA and RalB,
respectively.
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lized by Nishimura and Linder (26) in defining the pathway. To
do so, we introduced a Cys to Ser amino acid substitution at the
A1 position of each Ral isoform (C204S), designated RalA-CSIL
and RalB-CSLL. This substitution ablates palmitoylation but
not geranylgeranylation of the CAAX motif (26). Although we
did not observe a significant alteration in RalA-CSIL subcellu-
lar localization compared with WT RalA, we did find reduced
association of RalB-CSLL with the plasma membrane, along
with increased cytosolic accumulation (Figs. 1A and 6A). To
address the role of geranylgeranylation in Ral localization, we
generated nonprenylatable RalB-SCLL and RalA-SCIL C203S
mutants that are deficient in both the geranylgeranyl and
palmitate modifications. As expected (18), we found that these
mutants were completely disrupted in both plasma membrane
and endomembrane localization, and showed a diffuse cyto-
plasmic distribution including nuclear accumulation (Fig. 6B).
We used our MATLAB image processing script to quantify the
spatial distribution of the nonpalmitoylated and nonprenylated
mutant Ral proteins (Fig. 6C). We found that the alternative
dual lipid modification site of the RalB but not the RalA CAAX
motif affects subcellular localization to the plasma membrane.
In support of this conclusion, analysis of palmitoylation of
endogenous RalA and RalB revealed that the level of RalB
palmitoylation is 2-fold greater than that of RalA (Fig. 6, D
and E). An explanation of this result is that disruption of the
palmitoylatable cysteine of RalB also disrupted prenylation.
To address this, we inhibited geranylgeranylation of the
palmitoylation-defective RalB-CSLL mutant with the phar-
macological GGTase I inhibitor GGTI-2017. This treatment
resulted in a localization similar to that of the nongera-
nylgeranylated mutant RalB-SCLL (Fig. 6F). We conclude
that disruption of the palmitoylatable cysteine does not dis-
rupt geranylgeranylation.
Discussion
Despite their significant sequence, structural, and biochem-
ical similarities, RalA and RalB often serve divergent roles in
normal and neoplastic cell functions (1–3, 38). In this study, we
determined whether the CAAX-signaled posttranslational
modifications of proteolysis, isoprenylcysteine carboxylmeth-
ylation, and CAAX motif palmitoylation could contribute to the
distinct regulation of RalA and RalB. We found that both RalA
and RalB require RCE1 function for association with the plasma
membrane but not with endomembranes. In contrast, ICMT
deficiency disrupted RalB association with the plasma mem-
brane, whereas it disrupted RalA association with endosomes.
Assessing the consequences for Ral regulation, we found that
RCE1 deficiency increased the steady-state activation state of
both RalA and RalB, whereas ICMT deficiency regulated pro-
tein stability of RalB, but not RalA. Finally, we determined that
the A1 cysteine in the CA1A2X motif that leads to alternative
modification by the fatty acid palmitate was more significant
for RalB localization than for RalA. (Ral proteins do not contain
the upstream palmitoylatable cysteines present in the HVR of
FIGURE 5. ICMT deficiency increases RalB protein stability. A, RalB transcript levels were determined by TaqMan quantitative PCR analysis and
normalized to GABPB1 in a triplicate set of assays  S.E. Data displayed as relative to WT MEFs. B, endogenous RalB protein levels were quantified by
densitometry of Western blot and normalized to total protein. Data are displayed as relative to WT MEFs. Experiment performed in triplicate. C, WT and
Icmt/ MEFs were treated with 25 g/ml of cycloheximide and lysed at the indicated time points. Lysates were probed by Western blot for total RalB,
c-Myc, and for GAPDH to verify equivalent total protein. Protein levels from blots in panel were quantified by densitometry and normalized to 0 h.
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many Ras family small GTPases (27).) We conclude that the
differential roles of CAAX-signaled posttranslational modifica-
tions contribute significantly to the distinct regulation of RalA
and RalB.
Previous reports have reached conflicting conclusions
regarding the contribution of CAAX-signaled postprenyl
modifications in promoting proper subcellular localization
and membrane association of small GTPases. One study
showed that both RCE1 and ICMT were critical for localiza-
tion of farnesylated but not geranylgeranylated Ras and Rho
proteins (33), whereas we found that loss of either RCE1 or
ICMT did significantly impact the subcellular localization
and membrane association of geranylgeranylated Rho
GTPases (39). Although total membrane-bound RalA was
shown previously to be unaffected by loss of ICMT, its differ-
ential membrane compartmentalization was not examined, and
neither the membrane association nor localization of RalB was
investigated (33). In the present study, we have demonstrated
that the geranylgeranylated proteins RalA and RalB also require
RCE1 and ICMT for proper subcellular localization. Thus, we
conclude that the specific prenyl group modifying CAAX-con-
taining proteins is not sufficient by itself to predict dependence
on RCE1- and ICMT-catalyzed modifications. Because our
studies utilized RCE1- and ICMT-deficient cells, we recognize
that the consequences of their loss on Ral subcellular localiza-
tion may be indirect and not due specifically to disrupted mod-
ification of Ral itself. However, because no known CAAX-ter-
minating proteins have been described that interact with Ral,
we feel that our results do likely demonstrate direct roles of
these modifications in Ral function.
Although RalA and RalB both localize to the plasma mem-
brane and to endosomes, they exhibited striking differences in
the requirement of RCE1 and ICMT to facilitate their associa-
tion with these two membrane compartments. Loss of RCE1
disrupted association of both RalA and RalB with the plasma
membrane but not with endosomal membranes. In contrast,
loss of ICMT disrupted RalB but not RalA plasma membrane
association, whereas conversely disrupting endosome localiza-
tion of RalA but not RalB. Utilizing chimeric Ral proteins, we
determined that this differential regulation was due to
sequence divergence in the HVR rather than in the G-domain.
Both HVRs are largely lysine-rich sequences and contain no
other obvious membrane targeting information. Therefore,
how each HVR impacts the different consequences of ICMT
deficiency is not clear. However, they do diverge in the location
and sequence context of the serines that serve as phosphoryla-
tion sites for an isoform-specific variety of protein kinases (21–
25). We conclude that inhibition of ICMT is a possible
approach to blocking endosomal RalA function, and that this
would provide a level of selectivity over inhibition of RCE1.
Endosomal RalA function is important for cell processes
including exocytosis (5, 40), cytokinesis (6), and cell polarity
maintenance (7). Although it is unclear why prenylation of RalA
followed by RCE1 processing alone is sufficient to take RalA to
FIGURE 6. CA1AX palmitoylation dictates RalB subcellular localization. WT MEFs were transiently transfected with an expression construct encoding either
nonpalmitoylatable or nonprenylatable CAAX mutants of EGFP-RalA or EGFP-RalB, and then visualized by confocal microscopy. A, nonpalmitoylatable C204S
CA1AX mutants (RalA-CSIL or RalB-CSLL) or B, nonprenylatable C203S SAAX mutant (RalA-SCIL or RalB-SCLL). C, images from A and B were analyzed using our
MATLAB image processing script. D, hydroxylamine (NH2OH)-sensitive palmitoylated proteins from WT MEF lysates were immobilized on thiopropyl-Sephar-
ose resin using resin assisted capture (acyl-RAC), and palmitoylation of RalA and RalB was detected by immunoblotting. E, palmitoylation stoichiometry was
calculated by a ratio of the precipitate intensity to the input intensity. Data represent the mean  S.E. (n  6). F, WT MEFs were transiently transfected with the
nonprenylatable C203S mutant EGFP-RalB-CSLL as in panel B, but then treated with 25 M GGTI-2017 or dimethyl sulfoxide control for 24 h before visualization
by confocal microscopy.
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the plasma membrane, we previously found that the RhoB small
GTPase also showed the same dependence (39). Thus, with
some prenylated proteins, carboxylmethylation is dispensable
for plasma membrane association. It is also possible that,
because ICMT has additional substrates compared with RCE1,
mislocalization of these other proteins may be affecting RalA
and RalB differently.
In addition to altered subcellular localization, we also
observed consequences for Ral activation in RCE1-deficient
cells. We found that loss of RCE1 enhanced the steady-state
activity of RalA and RalB. We speculated that this altered activ-
ity is a consequence of their altered subcellular localization and
therefore of their interaction with RalGEFs or RalGAPs. Our
analyses found that the kinetics of Ral-GTP formation upon
EGF stimulation was consistent with increased activation by
RalGEFs rather than decreased inactivation by RalGAPs.
Because Ral proteins are displaced from the plasma membrane
in Rce1/ MEFs, there could be increased exposure of Ral to
specific RalGEFs on internal membranes. For example, the Ral-
GEF RGL2 is enriched on recycling endosomes (40). We con-
clude that RCE1 deficiency leads to aberrant RalA and RalB
activation, and suggest that therapeutic intervention targeting
RCE1 in Ras-dependent cancers could have pitfalls in uninten-
tional Ral effector pathway activation.
Another consequence of the loss of CAAX-signaled modifi-
cations was the increased steady-state level of RalB protein but
not RNA in Icmt/ MEFs. Previous studies reported that
ICMT-deficient, mutant K-Ras-transformed MEFs exhibited
increased Ras protein stabilization but conversely a decreased
half-life of RhoA protein but not RNA. However, no mechanis-
tic basis for these observations was described (36). Although
ubiquitination of Ral has been implicated in Ral-dependent
lipid raft trafficking (41), a degradation mechanism for Ral has
not been described. Perhaps RalB interaction with an E3 ubiq-
uitin ligase controlling Ral stability is affected by mislocal-
ization associated with loss of ICMT. Alternatively, the
absence of the methylation modification, independent of
altered localization, may alter RalB interaction with an E3
ligase. Consistent with this possibility, there is evidence that
prenylcysteine methylation of CAAX-containing proteins
can also play a role in regulating protein-protein interactions
(42– 45). In summary, our observations provide the first evi-
dence that RalB protein stability may be regulated by a post-
translational mechanism.
Pharmacologic inhibition of CAAX-signaled modifications
has been pursued extensively as an approach to inhibit Ras for
cancer treatment. Initial efforts targeted the first step, catalyzed
by farnesyltransferase. Unexpectedly, farnesyltransferase in-
hibitors were ineffective in blocking the membrane association
of K-Ras and N-Ras, due to farnesyltransferase inhibitor-in-
duced alternative prenylation by GGTase I (46, 47). Because
blocking Ras membrane association remains an attractive
approach (48), pharmacologic inhibition of RCE1 and ICMT
has been considered. Initial cell-based studies using RCE1- or
ICMT-deficient MEFs found that K-Ras-induced growth trans-
formation was impaired (36, 49). However, subsequent mouse
model studies indicate context-dependent consequences. In a
mouse model of K-Ras-induced myeloproliferative disease, loss
of ICMT ameliorated tumor growth, whereas loss of RCE1
accelerated it (50, 51). More recently, it was found that ICMT
deficiency enhanced K-Ras-driven pancreatic cancer develop-
ment (52). A logical explanation for these different conse-
quences for Ras-driven oncogenesis is that ablation of RCE1 or
ICMT expression alters the function of other CAAX-terminat-
ing prenylated proteins, including small GTPases such as Ral
and Rac that function downstream of Ras effector signaling, or
of Ras family proteins that can act as tumor suppressors (53). In
conclusion, given the large number of other RCE1 and ICMT
substrates, the usefulness of pharmacologic inhibitors of
RCE1 and ICMT as anti-Ras drugs will likely be highly
context-dependent.
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